Segment Information

6 Months Ended

Jun. 30, 2023

Segment Reporting [Abstract]

Segment Information

SEGMENT INFORMATIONThe Company operates and reports its results in four separate business segments consisting of the Biotechnology, Life Sciences, Diagnostics, and Environmental & Applied Solutions segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income and expense, interest and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs, including separation costs related to preparation for the anticipated separation of the Company’s Environmental & Applied Solutions business, and other costs not considered part of management’s evaluation of reportable segment operating performance. Intersegment amounts are not significant and are eliminated to arrive at consolidated totals. Segment results are shown below ($ in millions):

	Three-Month Period Ended				Six-Month Period Ended
	June 30, 2023		July 1, 2022		June 30, 2023		July 1, 2022
Sales:
Biotechnology	$	1,885	$	2,266	$	3,749	$	4,482
Life Sciences	1,796		1,701		3,505		3,367
Diagnostics	2,231		2,561		4,607		5,205
Environmental & Applied Solutions	1,245		1,223		2,463		2,385
Total	$	7,157	$	7,751	$	14,324	$	15,439
Operating profit:
Biotechnology	$	480	$	824	$	1,076	$	1,624
Life Sciences	340		350		661		668
Diagnostics	424		800		1,101		1,686
Environmental & Applied Solutions	302		307		601		543
Other	(117)		(76)		(216)		(144)
Total	$	1,429	$	2,205	$	3,223	$	4,377